Zimmermann A, Urbanek R, Kühr J, Stephan V
Universitäts-Kinderklinik Freiburg.
Monatsschr Kinderheilkd. 1992 Jan;140(1):51-6.
Histamine is partly metabolized to a stabile metabolite N-methyl-histamine and excreted in the urine. We analysed the degradation of infused histamine and the N-methyl-histamine-excretion in atopic and normal individuals as in patients with a bronchoconstriction due to allergen/exercise challenge. N-methyl-histamine was determined by a newly developed radioimmunoassay. 60 controls and 38 atopic individuals were investigated. There is a proportional increase of N-methyl-histamine in the urine in young children. However, no significant difference between allergic and non-allergic individuals was found. After parenteral administration of a standardized amount of histamine 12% of the applied amount was secreted in the urine as N-methylhistamine. The most significant increase of N-methylhistamine-excretion was observed in the first hour after application. Only an 0.1% rise of N-methyl-histamine was observed following an oral administration of histamine. Neither bronchial challenge with specific allergen nor physical exercise elicited significant changes of N-methylhistamine excretion. The secretion of N-methyl-histamine demonstrates the degradation of histamine in the circulation, the measurement oft this metabolite in the urine should be considered when analysing the cause of severe systemic allergic reaction as anaphylaxis but not asthma or atopic disposition.
组胺部分代谢为稳定代谢产物N-甲基组胺,并随尿液排出。我们分析了输注组胺的降解情况以及特应性个体、正常个体和因过敏原/运动激发导致支气管收缩的患者尿液中N-甲基组胺的排泄情况。N-甲基组胺通过新开发的放射免疫测定法进行测定。研究了60名对照者和38名特应性个体。幼儿尿液中N-甲基组胺呈比例增加。然而,未发现过敏个体与非过敏个体之间存在显著差异。经肠胃外给予标准量的组胺后,所给予量的12%以N-甲基组胺的形式分泌到尿液中。应用组胺后第一小时观察到N-甲基组胺排泄量增加最为显著。口服组胺后仅观察到N-甲基组胺有0.1%的升高。特异性过敏原支气管激发试验和体育锻炼均未引起N-甲基组胺排泄的显著变化。N-甲基组胺的分泌表明组胺在循环中的降解,在分析严重全身性过敏反应如过敏反应而非哮喘或特应性体质的病因时,应考虑测定尿液中这种代谢产物。